Current Concepts in Surgical Pathology 2020
$100.00 – $120.00
Harvard Medical School and Massachusetts General Hospital Clinical Update
Explore Key Topics
Current Concepts in Surgical Pathology presents a broad overview of key areas of surgical pathology and intends to update both academic and community pathologists with new advances in the field. Lead by a renowned pathologist, this CME program includes case-based lectures on topics like lymph node diagnosis, gestational trophoblast disease, DLBCL, inflammatory bowel disease, and more. It will help you to better:
– Apply new criteria for pathologic diagnoses in multiple areas of surgical pathology
– Recognize unusual entities
– Assess the decision making process used to arrive at specific diagnoses
– Utilize contemporary tumor classification systems
– Apply IHC and/or molecular studies judiciously to establish or confirm diagnoses
Current Concepts in Surgical Pathology 2020 (36)
| 1 | Deceptive Patterns and Mimics of Invasive Breast Cancer – Melinda J. Lerwill, MD |
| 2 | Approach to Lymph Node Diagnosis – Judith A. Ferry, MD |
| 3 | Non-Invasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features and Thyroid Tumors with a Follicular Pattern – William C. Faquin, MD, PhD |
| 4 | Problems in Ovarian Tumor Interpretation – Mistakes that May Cause Harm to the Patient or Embarrass the Pathologist: Part I – Robert H. Young, MD |
| 5 | Diffuse Large B-Cell Lymphoma: Problems and Peculiarities in Diagnosis – Aliyah R. Sohani, MD |
| 6 | Placental Pathologies that Necessitate Intervention – Drucilla J. Roberts, MD |
| 7 | lnflammatory Bowel Disease: Challenges and Controversies – Joseph Misdraji, MD |
| 8 | Problems in Ovarian Tumor Interpretation: Part II – Robert H. Young, MD |
| 9 | Myelodysplasia and Myeloproliferative Neoplasms – Robert P. Hasserjian, MD |
| 10 | Ductal Carcinoma In-Situ: Diagnostic Evaluation and Problematic Patterns – Melinda J. Lerwill, MD |
| 11 | Neuroendocrine Tumors of the Gastrointestinal and Pancreaticobiliary Tracts – Vikram Deshpande, MD |
| 12 | Gestational Trophoblast Disease – Drucilla J. Roberts, MD |
| 13 | Pancreaticobiliary Neoplasms and their Mimics – Vikram Deshpande, MD |
| 14 | Interstitial Lung Disease – Lida P. Hariri, MD, PhD |
| 15 | Classification and Genetics of Familial Thyroid Carcinoma – Vania Nosé, MD, PhD |
| 16 | Polyps and Other Precursors Lesions in the Colon – Lawrence R. Zukerberg, MD |
| 17 | Mesenchymal Neoplasms of the Uterus – Esther Oliva, MD |
| 18 | Update on Gastritis – Lawrence R. Zukerberg, MD |
| 19 | Approach to Ancillary Testing in Epithelioid Soft Tissue Tumors – Ivan A. Chebib, MD |
| 20 | Lung Carcinoma: Selected Issues in Histologic Classification – Mari Mino-Kenudson, MD |
| 21 | Practical Aspects of Meningioma Diagnosis – David N. Louis, MD |
| 22 | Neuropathology Frozen Section Interpretation: Problems and Pitfalls – Maria Martinez-Lage, MD |
| 23 | Hodgkin’s Lymphoma and Its Differential Diagnosis – Judith A. Ferry, MD |
| 24 | The Application of Immunohistochemistry in the Differential Diagnosis of Ovarian Tumors – Esther Oliva, MD |
| 25 | Common Problems in Liver Biopsy Interpretation – Joseph Misdraji, MD |
| 26 | Salivary Gland Pathology – Peter M. Sadow, MD, PhD |
| 27 | Mucinous Lesions of the Breast – Veerle I.J. Bossuyt, MD |
| 28 | Vasculitis – James R. Stone, MD |
| 29 | Follicular Lymphoma – Abner Louissaint, Jr., MD, PhD |
| 30 | Renal Tumors: An Update – Kristine Cornejo, MD |
| 31 | Clinically Important Diagnoses in Sinonasal Pathology – William C. Faquin, MD, PhD |
| 32 | Adrenal Pathology – Peter M. Sadow, MD, PhD |
| 33 | Grading and Staging of Urologic Cancers: An Interactive Exercise – Chin-Lee Wu, MD, PhD |
| 34 | Pleomorphic Lobular and Variant Forms of Mammary Carcinoma In Situ – Travis L. Rice-Stitt, MD |
| 35 | Evaluation of Treatment-Related Changes in Breast Cancer – Elena F. Brachtel, MD |
| 36 | Instructive Cases – William C. Faquin, MD, PhD; Judith A. Ferry, MD; and Melinda J. Lerwill, MD |
Learning Objectives
After viewing this program, the participant will be better able to:
– Apply new criteria for pathologic diagnoses in multiple areas of surgical pathology”
– Recognize unusual entities
– Evaluate the decision making process used to arrive at specific diagnoses
– Utilize contemporary tumor classification systems
– Apply immunohistochemistry and/or molecular studies judiciously to establish or confirm diagnoses
Intended Audience
This course is targeted to physicians who specialize in pathology.
Designation
Date of Original Release: January 15, 2020
Date of Credit Termination: January 15, 2023
Estimated Time to Complete: 29 hours
Related products
